Federal contractors / ILLUMINA, INC.

Federal contract award

75F40121P00123

PREVENTIVE MAINTENANCE AGREEMENT AND REPAIR FOR AN ILLUMINA NEXT-SEQ 500 DNA SEQUENCER WITH 3 (1-YEAR OPTION PERIODS)

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeFDA OFFICE OF ACQ GRANT SVCS
NAICS811219
PSCJ066 — Maintenance, Repair and Rebuilding of Equipment: Instruments and Laboratory Equipment
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIRM FIXED PRICE
Obligations$150.4K
Current contract value$150.4K
Potential contract value / ceiling$150.4K
Start dateMar 24, 2021
Current end dateJun 16, 2024
Potential end dateJun 16, 2025
Latest award activityApr 3, 2024
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 6 of 6 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Apr 3, 2024P00005$40.0KPREVENTIVE MAINTENANCE AGREEMENT AND REPAIR FOR AN ILLUMINA NEXT-SEQ 500 DNA SEQUENCER WITH 3 (1-YEAR OPTION PERIODS)
Mar 8, 2023P00004$38.4KPREVENTIVE MAINTENANCE AGREEMENT AND REPAIR FOR AN ILLUMINA NEXT-SEQ 500 DNA SEQUENCER WITH 3 (1-YEAR OPTION PERIODS)
Jun 3, 2022P00003$36.4KPREVENTIVE MAINTENANCE AGREEMENT AND REPAIR FOR AN ILLUMINA NEXT-SEQ 500 DNA SEQUENCER WITH 3 (1-YEAR OPTION PERIODS)
Apr 7, 2022P00002$0IPP UPDATE - PREVENTIVE MAINTENANCE AGREEMENT AND REPAIR FOR AN ILLUMINA NEXT-SEQ 500 DNA SEQUENCER WITH 3 (1-YEAR OPTION PERIODS)
Nov 5, 2021P00001$0EO14042 INCORPORATING FAR 52.223-99, ENSURING ADEQUATE COVID-19 SAFETY PROTOCOLS FOR FEDERAL CONTRACTORS (OCT 2021) (DEVIATION).
Mar 24, 20210$35.5KPREVENTIVE MAINTENANCE AGREEMENT AND REPAIR FOR AN ILLUMINA NEXT-SEQ 500 DNA SEQUENCER WITH 3 (1-YEAR OPTION PERIODS)

Buyer contacts from matching notices

Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.

ContactRolePublished contact methodsEvidenceSource date
Yolanda RankinContactyolanda.rankin@fda.hhs.gov
2142534954		SourceMar 8, 2021
Yolanda RankinContactyolanda.rankin@fda.hhs.gov
2142534954		SourceFeb 19, 2021

Research next steps

  1. Verify whether remaining options may extend performance beyond the current end date.
  2. Check the stated set-aside against the solicitation and current certifications.
  3. Review the award scope and buyer evidence before making a bid/no-bid decision.